SC

Subhash Chandra Srivastava

Active Director Director DIN 09441394
DIN 09441394 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Subhash Chandra Srivastava

Data last updated:

Subhash Chandra Srivastava is a Director at Turnex Laboratories Private Limited (since 2021). The company operates in Chemicals.

DIN 09441394
Primary Designation Director
Industry Chemicals
First Appointment 20 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Turnex Laboratories Private Limited U24100MH2021PTC373591
Director20 Dec 20212021Active

Board colleagues of Subhash Chandra Srivastava

NameDINCompanyDesignation
Shalini Srivastava09441393Turnex Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Turnex Laboratories Private Limited
Premium access

Shareholding and investment profile for Subhash Chandra Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhash Chandra Srivastava

Subhash Chandra Srivastava currently holds 1 directorship: Turnex Laboratories Private Limited (Director, since 20 Dec 2021).

Subhash Chandra Srivastava was first appointed on 20 Dec 2021 as Director at Turnex Laboratories Private Limited.

The current boards of Subhash Chandra Srivastava's companies include Shalini Srivastava (Turnex Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available